Please login to the form below

New sales and marketing approach required for Orphan drugs.

The small number of patients who may potentially benefit from orphan drugs means that while interest in them is strong, convincing cash constrained healthcare payers of their efficacy and value is a major hurdle for pharma marketers.

Read the full article here:

4th April 2014